Evidence map›Paper›PMID 33444179›Full record

ArticleBMJ open2020

Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK.

Jo Brett, Emma L Davies, Fiona Matley, Paul Aveyard, Mary Wells, David Foxcroft, Brian Nicholson, Shiroma De Silva Minor, Lesley Sinclair, Sarah Jakes and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jo BrettHealth & Life Sciences, Oxford Brookes University, Oxford, UK jbrett@brookes.ac.uk.ORCID 0000-0002-5116-4238
Emma L DaviesDepartment of Psychology, Social Workand Public Health Oxford Brookes University, Oxford, UK.
Fiona MatleyHealth & Life Sciences, Oxford Brookes University, Oxford, UK.
Paul AveyardNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-1802-4217
Mary WellsDepartment of Surgery & Cancer, Faculty of Medicine, Imperial College Healthcare NHS Trust, London, UK.ORCID 0000-0001-5789-2773
David FoxcroftDepartment of Psychology, Social Workand Public Health Oxford Brookes University, Oxford, UK.ORCID 0000-0001-9752-7527
Brian NicholsonNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-0661-7362
Shiroma De Silva MinorCancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Lesley SinclairMolecular, Genetic and Population Health Sciences, University of Edinburgh, Edinburgh, Scotland.
Sarah JakesVaper Representative, London, UK.
Eila WatsonHealth & Life Sciences, Oxford Brookes University, Oxford, UK.ORCID 0000-0002-3592-1315

Funding

Cancer Research UK 23877Cancer Research UK A24355
6 · The paper itself

Abstract

objectivesTo explore UK clinicians' beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer.

designCross-sectional online survey.

settingEngland, Wales, Scotland and Northern Ireland.

participantsClinicians involved in the care of patients with cancer. PRIMARY AND SECONDARY OUTCOMES: Behavioural Change Wheel capability, opportunity and motivation to perform a behaviour, knowledge, beliefs, current practice around e-cigarettes and other smoking cessation practices.

methodClinicians (n=506) completed an online survey to assess beliefs and behaviours around e-cigarettes and other smoking cessation practices for patients with cancer. Behavioural factors associated with recommending e-cigarettes in practice were assessed.

results29% of clinicians would not recommend e-cigarettes to patients with cancer who continue to smoke. Factors associated with recommendation include smoking cessation knowledge (OR 1.56, 95% CI 1.01 to 2.44) and e-cigarette knowledge (OR 1.64, 95% CI 1.06 to 2.55), engagement with patients regarding smoking cessation (OR 2.12, 95% CI 1.12 to 4.03), belief in the effectiveness of e-cigarettes (OR 2.36 95% CI 1.61 to 3.47) and belief in sufficient evidence on e-cigarettes (OR 2.08 95% CI 1.10 to 4.00) and how comfortable they felt discussing e-cigarettes with patients (OR 1.57 95% CI 1.04 to 2.36).

conclusionMany clinicians providing cancer care to patients who smoke do not recommend e-cigarettes as a smoking cessation aid and were unaware of national guidance supporting recommendation of e-cigarettes as a smoking cessation aid.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationCross-Sectional StudiesFemaleHumansMaleNeoplasmsState MedicineUnited Kingdomepidemiologyhealth policymedical education & trainingoncologypublic healthquality in health care

Identifiers

PMID33444179
PMCPMC7678366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.